Price T Rowe Associates Inc. MD Trims Stake in Oscar Health, Inc. (NYSE:OSCR)

Price T Rowe Associates Inc. MD trimmed its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 11.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,744,902 shares of the company's stock after selling 643,159 shares during the period. Price T Rowe Associates Inc. MD owned 1.92% of Oscar Health worth $63,773,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after buying an additional 8,051,379 shares in the last quarter. BIT Capital GmbH grew its position in shares of Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. raised its stake in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. Clearbridge Investments LLC purchased a new position in Oscar Health in the 4th quarter worth approximately $19,088,000. Finally, American Century Companies Inc. boosted its stake in Oscar Health by 185.6% in the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock worth $17,273,000 after purchasing an additional 835,144 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $20.21.

Oscar Health Price Performance

Oscar Health stock traded up $0.14 during mid-day trading on Friday, reaching $13.19. 4,191,933 shares of the company's stock traded hands, compared to its average volume of 3,918,047. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The company has a market cap of $3.30 billion, a price-to-earnings ratio of -659.17 and a beta of 1.75. The stock has a 50 day moving average of $13.30 and a two-hundred day moving average of $14.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Equities analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.